OAC
ARMP icon

OMERS Administration Corp’s Armata Pharmaceuticals ARMP Stock Holding History

OMERS Administration Corp’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,125
Closed -$177K – 1102
2025
Q4 		$177K Buy
+28,125
New +$154K ﹤0.01% 926

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMERS Administration Corp's ARMP Position: Q1 2026 in Review

OMERS Administration Corp sold out of Armata Pharmaceuticals (ARMP) in Q1 2026, closing a stake of 28,125 shares — an estimated $177K sold.

OMERS Administration Corp first reported a position in ARMP in Q4 2025 and held it in 1 quarter. The position peaked at $177K in Q4 2025. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • OMERS Administration Corp reported no remaining Armata Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 28,125 Armata Pharmaceuticals shares in Q1 2026, an estimated $177K.
  • OMERS Administration Corp first reported a position in Armata Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Armata Pharmaceuticals position peaked at $177K in Q4 2025.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.